Trials / Unknown
UnknownNCT04251039
in Patients With SCAD Undergoing Complex PCI, the RESPONSE Study"
"Efficacy and Safety of Oral/iv Therapy (Cangrelor) in Patients With SCAD Undergoing Complex PCI, the RESPONSE Study"
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 550 (estimated)
- Sponsor
- Fondazione GISE Onlus · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of Efficacy/Safety in Cangrelor use in patients with SCAD undergoing complex PCI. Prospective, observational, multicenter registry.
Detailed description
SCAD patients routinely in the Italian centers undergo complex PCIs with pre-treatment with P2Y12 inhibitors or with P2Y12 inhibitors administration after procedure. This implies that participants receive interventions as part of routine medical care, and that researchers actually observe the effect of the intervention.
Conditions
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2020-01-31
- Last updated
- 2022-07-28
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04251039. Inclusion in this directory is not an endorsement.